Actively Recruiting
Study of Gene Expression in Colorectal Polyps Related to Metabolic Dysfunction-Associated Steatohepatitis MASH
Led by Shanghai East Hospital · Updated on 2026-03-11
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the molecular features of colorectal polyps in patients with metabolic dysfunction-associated steatohepatitis MASH compared to those without fatty liver. The study aims to identify gene expression differences and potential transcriptomic biomarkers that could indicate high-risk polyps in MASH patients. This observational study follows patients scheduled for colonoscopic polypectomy as part of their routine care. Participants will provide small portions of their polyp tissue for single-cell RNA sequencing or pathological examination, as well as residual plasma samples from routine blood tests. The study includes two groups a control group without fatty liver and a MASH group, with detailed assessments such as FibroScan to evaluate liver steatosis and fibrosis. Tissue samples will be processed and analyzed for high-risk transcriptional molecule expression. During the study, participants will have their medical histories, liver ultrasounds, blood tests, and other examinations recorded. Follow-up occurs every six months to monitor outcomes. The main outcome measure is the expression levels of high-risk transcriptional molecules in colorectal polyp tissues. Safety monitoring includes managing risks related to blood draws and colonoscopic polypectomy, which are part of routine clinical procedures. Total participation lasts through the initial assessments and ongoing six-month follow-ups.
CONDITIONS
Brief Title
High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps
Research Team
T
Ting Mao, Bachelor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here